Increasing data has indicated that the expression or alterations of AQP3 in the gut may be associated with several intestinal disorders, such as inflammatory bowel disease, diarrhea, intestinal barrier injury, irritable bowel syndrome, intestinal oxidative stress, and autophagy (Meli et al., 2018). Here, AQP3 is linked to irritable bowel syndrome.